Abilify and Renal cell carcinoma - a phase IV clinical study of FDA data

Summary:

Renal cell carcinoma is reported as a side effect among people who take Abilify (aripiprazole), especially for people who are male, 60+ old, have been taking the drug for 6 - 12 months also take Cymbalta, and have Schizophrenia.

The phase IV clinical study analyzes which people have Renal cell carcinoma when taking Abilify. It is created by eHealthMe based on reports of 97,308 people who have side effects when taking Abilify from the FDA, and is updated regularly.

What is Abilify?

Abilify has active ingredients of aripiprazole. It is often used in depression. eHealthMe is studying from 101,456 Abilify users. Check the latest studies of Abilify.

What is Renal cell carcinoma?

Renal cell carcinoma (a kidney cancer) is found to be associated with 786 drugs and 1,339 conditions by eHealthMe. Check the latest studies of Renal cell carcinoma.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 30, 2026

97,308 people reported to have side effects when taking Abilify.
Among them, 23 people (0.02%) have Renal cell carcinoma.

Could Abilify cause Renal cell carcinoma?

Among these 23 people:

How long have people been on Abilify when they have Renal cell carcinoma? *

What is the gender of people who have Renal cell carcinoma when taking Abilify? *

female: 47.83 %
male: 52.17 %

What is the age of people who have Renal cell carcinoma when taking Abilify? *

What are other drugs people take besides Abilify? *

What are other side effects people have besides Renal cell carcinoma? *

High Blood Cholesterol: 7 people, 30.43%
Muscle Spasms (muscle contraction): 7 people, 30.43%
Nausea (feeling of having an urge to vomit): 7 people, 30.43%
Renal Mass (mass in kidney): 6 people, 26.09%
Abdominal Distension: 5 people, 21.74%
Blood Glucose Increased: 5 people, 21.74%
Hypometabolism (abnormal decrease in metabolic rate): 5 people, 21.74%
Lymph Follicular Hypertrophy (an increase in the size of the lymph node follicles): 5 people, 21.74%
Musculoskeletal Discomfort (discomfort in the body's muscles, joints, tendons, ligaments and nerves): 5 people, 21.74%
Feeling Abnormal: 5 people, 21.74%

What are the existing conditions these people have? *

Schizophrenia (a mental disorder characterized by a breakdown of thought processes): 6 people, 26.09%
Mood Swings (an extreme or rapid change in mood): 5 people, 21.74%
Arthritis (form of joint disorder that involves inflammation of one or more joints): 2 people, 8.70%
Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 2 people, 8.70%
Relapsing-Remitting Multiple Sclerosis (reoccurrence of an inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 2 people, 8.70%
Psychotic Disorder: 2 people, 8.70%
Neurogenic Bladder (the normal function of the bladder is to store and empty urine in a coordinated, controlled fashion): 2 people, 8.70%
Migraine (headache): 2 people, 8.70%
High Blood Pressure: 2 people, 8.70%
Type 2 Diabetes: 1 person, 4.35%

* Approximation only. Some reports may have incomplete information.

Do you take Abilify and have Renal cell carcinoma?

- Check whether Renal cell carcinoma is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Abilify:

Abilify (101,456 reports)

Browse all side effects of Abilify:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Renal cell carcinoma:

Renal cell carcinoma (786 drugs)

Browse all the conditions that are associated with Renal cell carcinoma:

Renal cell carcinoma (1,339 conditions)

Related publications that referenced our studies

Cetin, M., Celik, M., Cakici, M., Polat, M., & Suner, A, "Aripiprazole-Induced Hoarseness", Turk Psikiyatri Dergisi, 2018 Jan .
Cetin M, Celik M, Cakici M, Polat M, Suner A, "Aripiprazole induced non-cardiogenic pulmonary edema: a case report", Turk Psikiyatri Dergisi, 2014 Dec .
Cetin, M., Celik, M., Cakici, M., Polat, M., & Suner, A, "Aripiprazole-Induced Hoarseness", Turk Psikiyatri Dergisi, 2018 Jan .
Cetin M, Celik M, Cakici M, Polat M, Suner A, "Aripiprazole induced non-cardiogenic pulmonary edema: a case report", Turk Psikiyatri Dergisi, 2014 Dec .

How the study uses the data?

The study uses data from the FDA. It is based on aripiprazole (the active ingredients of Abilify) and Abilify (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.